ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
125 hedge funds and large institutions have $514M invested in Adamas Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 47 increasing their positions, 33 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
24% less capital invested
Capital invested by funds: $676M → $514M (-$162M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
125
Holding in Top 10
3
Calls
$4.46M
Puts
$2.43M
Top Buyers
| 1 | +$9.51M | |
| 2 | +$7.37M | |
| 3 | +$5M | |
| 4 |
BWCA
Brenner West Capital Advisors
New York
|
+$4.48M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.32M |
Top Sellers
| 1 | -$15M | |
| 2 | -$13.3M | |
| 3 | -$7.62M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.1M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.52M |